Notably, the elevated expression of SLC2A1, which encodes glucose transporter 1 (GLUT1), enhances cancer cell uptake of glucose, thereby reprogramming cellular metabolic pathways (Li et al. 2023). This evidence concerns the gene SLC2A1 and cancer.